Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

Response from Leo regarding "Cherry Picking" to WI

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
(Total Views: 367)
Posted On: 04/09/2018 4:25:44 PM
Posted By: Mo
Response from Leo regarding "Cherry Picking" to WILD_4_IPIX copied from the swamp:

WILD_4_IPIX
Monday, 04/09/18 04:15:32 PM
Re: None
0
Post # of 223680

Response from Leo re: Cherry Picking .... this is Public Information

David,

Please note that Soligenix who showed a negligible reduction in the incidence of SOM in their Phase 2 study is limiting their Phase 3 study to those "Scheduled to receive cisplatin chemotherapy of 80-100 mg/m²” https://www.clinicaltrials.gov/ct2/show/NCT03...amp;rank=2

a 7% relative reduction in the incidence of SOM when compared to placebo (from 74% in the placebo group to 69% in the dusquetide group; Supplemental Table 1). In the 6.0 mg/kg group, the results were inconsistent across outcomes (Supplemental Table 1).
https://www.sciencedirect.com/science/article...&ccp=y

The answer is that this is not cherry picking as this is the population most affected. That is why trials for SOM are usually limited to HNC.

I hope this helps, but I now realize we may need to explain this to shareholders in future releases.


Best wishes,
Leo Ehrlich | CEO |
Innovation Pharmaceuticals Inc.
100 Cummings Center, Suite 151-B Beverly, MA 01915
http://www.iPharminc.com


(3)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us